{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:47:54Z","timestamp":1792626474110,"version":"4.5.0"},"reference-count":76,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Polish Diabetes Association for the project entitled \u201cMetabolic Risk Factors for the Development of Colorectal Polyps\u201d"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Objectives: Type 2 diabetes (T2D) has been increasingly associated with a heightened risk of various gastrointestinal (GI) cancers. This narrative review aims to synthesise current evidence on the link between newly diagnosed T2D and GI malignancies, and to propose a clinical framework for risk-adapted cancer vigilance. Methods: We conducted a narrative review of the literature focusing on the association between T2D and GI cancers, including colorectal, pancreatic, liver, gastric, and biliary malignancies. We examined shared risk factors, underlying biological mechanisms, and emerging insights into pathophysiology. Results: Epidemiological and mechanistic studies suggest that chronic hyperglycaemia, hyperinsulinemia, insulin resistance, inflammation, and gut microbiota alterations contribute to cancer development in patients with T2D. Despite these findings, current screening guidelines do not provide T2D-specific recommendations for GI cancer surveillance. Conclusions: T2D is an emerging risk factor for several GI malignancies. Clinicians should be aware of this association and consider individualised assessment in newly diagnosed patients. The proposed algorithm is intended to stimulate further discussion and guide future research. Prospective studies are needed to evaluate the effectiveness and feasibility of targeted screening strategies in this high-risk population.<\/jats:p>","DOI":"10.3390\/cancers17182989","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T13:43:02Z","timestamp":1757684582000},"page":"2989","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Type 2 Diabetes and Gastrointestinal Cancers: Risk Associations and Awareness of Screening Challenges"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0616-5992","authenticated-orcid":false,"given":"Monika","family":"Storman","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2396-8885","authenticated-orcid":false,"given":"Leszek","family":"Czupryniak","sequence":"additional","affiliation":[{"name":"Department of Diabetology and Internal Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"ref_1","unstructured":"International Diabetes Federation (2021). Diabetes Atlas, International Diabetes Federation. [10th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/dcS13-2001","article-title":"Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer","volume":"36","author":"Gallagher","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Srivastava, S.P., and Goodwin, J.E. (2020). Cancer biology and prevention in diabetes. Cells, 9.","DOI":"10.3390\/cells9061380"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Tsilidis, K.K., Kasimis, J.C., Lopez, D.S., Ntzani, E.E., and Ioannidis, J.P. (2015). Type 2 diabetes and cancer: Umbrella review of meta-analyses of observational studies. BMJ, 350.","DOI":"10.1136\/bmj.g7607"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jdi.12725","article-title":"Unfolding link between diabetes and cancer","volume":"9","author":"Noto","year":"2018","journal-title":"J. Diabetes Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4093\/dmj.2014.38.5.330","article-title":"Hyperglycemia as a risk factor for cancer progression","volume":"38","author":"Ryu","year":"2014","journal-title":"Diabetes Metab. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41575-018-0038-1","article-title":"Adiposity and gastrointestinal cancers: Epidemiology, mechanisms and future directions","volume":"15","author":"Murphy","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.gastha.2021.10.009","article-title":"Type 2 diabetes and risk of early-onset colorectal cancer","volume":"1","author":"Li","year":"2022","journal-title":"Gastro Hep Adv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bpg.2014.07.006","article-title":"Mechanisms behind the link between obesity and gastrointestinal cancers","volume":"28","author":"Tilg","year":"2014","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.dsx.2019.01.041","article-title":"How the association between obesity and inflammation may lead to insulin resistance and cancer","volume":"13","author":"Amin","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kasprzak, A. (2021). Insulin-like growth factor 1 (IGF-1) signaling in glucose metabolism in colorectal cancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126434"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/ijpvm.IJPVM_266_20","article-title":"Crossroad between obesity and gastrointestinal cancers: A review of molecular mechanisms","volume":"12","author":"Moodi","year":"2021","journal-title":"Int. J. Prev. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Chen, B., Li, J., Chi, D., Wang, Y., Yu, Q., Wang, D., Zhang, X., Song, X., Wang, W., and Wang, Z. (2019). Non-coding RNAs in IGF-1R signaling regulation: The underlying pathophysiological link between diabetes and cancer. Cells, 8.","DOI":"10.3390\/cells8121638"},{"key":"ref_14","first-page":"104","article-title":"Gastrointestinal cancer incidence in type 2 diabetes mellitus: Results from a large population-based cohort study in the UK","volume":"55","author":"Peeters","year":"2018","journal-title":"Cancer Epidemiol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Chiefari, E., Mirabelli, M., La Vignera, S., Colao, A., and Foti, D. (2021). Insulin resistance and cancer: In search for a causal link. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222011137"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/endrev\/bnad005","article-title":"Insulin\/IGF axis and the Receptor for Advanced Glycation End Products: Role in meta-inflammation and potential in cancer therapy","volume":"44","author":"Vella","year":"2023","journal-title":"Endocr. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Szukiewicz, D. (2023). Molecular mechanisms for the vicious cycle between insulin resistance and the inflammatory response in obesity. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202305.1026.v1"},{"key":"ref_18","first-page":"483","article-title":"Effects of metformin on survival outcomes of pancreatic cancer patients with diabetes: A meta-analysis","volume":"8","author":"Xin","year":"2018","journal-title":"Mol. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1111\/j.1572-0241.2007.01480.x","article-title":"Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: A retrospective review of CT scans and fasting glucose values prior to diagnosis","volume":"102","author":"Takahashi","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00006676-199405000-00008","article-title":"Beta-cell function in pancreatic adenocarcinoma","volume":"9","author":"Basso","year":"1994","journal-title":"Pancreas"},{"key":"ref_21","first-page":"189","article-title":"Diabetes and risk of pancreatic cancer: A pooled analysis of three large case-control studies","volume":"22","author":"Li","year":"2011","journal-title":"Cancer Causes Control."},{"key":"ref_22","first-page":"101","article-title":"Pancreatic cancer is associated with impaired glucose metabolism","volume":"159","author":"Permert","year":"1993","journal-title":"Eur. J. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ejca.2011.03.003","article-title":"Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies","volume":"47","author":"Ben","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.gastro.2005.05.007","article-title":"Probability of pancreatic cancer following diabetes: A population-based study","volume":"129","author":"Chari","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/SLA.0b013e3181b2fafa","article-title":"A prospective diagnostic accuracy study of 18F-FDG PET\/CT, multidetector row CT, and MRI in primary diagnosis and staging of pancreatic cancer","volume":"250","author":"Kauhanen","year":"2009","journal-title":"Ann. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2214\/ajr.173.3.10470884","article-title":"Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: A comparative study with ROC analysis","volume":"173","author":"Sheridan","year":"1999","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MEG.0000000000002052","article-title":"A clinical prediction model to assess risk for pancreatic cancer among patients with pre-diabetes","volume":"34","author":"Boursi","year":"2022","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2018.05.023","article-title":"Model to determine risk of pancreatic cancer in patients with new-onset diabetes","volume":"155","author":"Sharma","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/cncr.10493","article-title":"A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus","volume":"94","author":"Ogawa","year":"2002","journal-title":"Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.pan.2015.12.005","article-title":"New-onset type 2 diabetes mellitus\u2014A high-risk group suitable for the screening of pancreatic cancer?","volume":"16","author":"Terzin","year":"2016","journal-title":"Pancreatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.pan.2018.05.022","article-title":"Type 2 diabetes mellitus and pancreatic cancer risk: An independent etiological relation?","volume":"18","author":"Malats","year":"2018","journal-title":"Pancreatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/gutjnl-2012-303108","article-title":"International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer","volume":"62","author":"Canto","year":"2014","journal-title":"Gut"},{"key":"ref_33","unstructured":"International Agency for Research on Cancer Global Cancer Observatory: Cancer Today, IARC."},{"key":"ref_34","unstructured":"(2023, July 07). Polish National Cancer Registry. Available online: https:\/\/onkologia.org.pl."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.7326\/0003-4819-130-11-199906010-00003","article-title":"Association between body mass and adenocarcinoma of the esophagus and gastric cardia","volume":"130","author":"Lagergren","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e7944","DOI":"10.1097\/MD.0000000000007944","article-title":"Diabetes mellitus carries a risk of esophageal cancer: A meta-analysis","volume":"96","author":"Xu","year":"2017","journal-title":"Medicine"},{"key":"ref_37","first-page":"717","article-title":"Gastroparesis and dyspepsia in patients with diabetes mellitus","volume":"7","author":"Mearin","year":"1995","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00535-008-2289-z","article-title":"Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease","volume":"44","author":"Kamiya","year":"2009","journal-title":"J. Gastroenterol."},{"key":"ref_39","first-page":"S2","article-title":"Epidemiology and biology of esophageal cancer","volume":"3","author":"Demeester","year":"2009","journal-title":"Gastrointest. Cancer Res."},{"key":"ref_40","first-page":"263","article-title":"Risk of esophageal cancer in diabetes mellitus: A meta-analysis of observational studies","volume":"23","author":"Huang","year":"2012","journal-title":"Cancer Causes Control"},{"key":"ref_41","unstructured":"National Cancer Institute (2023, July 07). Esophageal Cancer Screening. American Cancer Society, Available online: https:\/\/cancer.gov."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/j.gastro.2018.04.026","article-title":"Endoscopic Screening in Asian Countries Is Associated With Reduced Gastric Cancer Mortality: A Meta-analysis and Systematic Review","volume":"155","author":"Zhang","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/MEG.0b013e32834b8d73","article-title":"Diabetes mellitus and risk of gastric cancer: A systematic review and meta-analysis of observational studies","volume":"23","author":"Ge","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/1477-3163.90481","article-title":"Diabetes mellitus and gastric carcinoma: Is there an association?","volume":"10","author":"Marimuthu","year":"2011","journal-title":"J. Carcinog."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0031-1297969","article-title":"Diabetes mellitus and incidence and mortality of gastric cancer: A meta-analysis","volume":"120","author":"Tian","year":"2012","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3748\/wjg.v19.i6.936","article-title":"Pre-existing diabetes mellitus increases the risk of gastric cancer: A meta-analysis","volume":"19","author":"Yoon","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1053\/j.gastro.2008.12.045","article-title":"Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: A population-based cohort study","volume":"136","author":"Ikeda","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/diacare.28.4.789","article-title":"Impact of fasting plasma glucose levels on gastric cancer incidence in a general Japanese population: The Hisayama study","volume":"28","author":"Yamagata","year":"2005","journal-title":"Diabetes Care"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3748\/wjg.v20.i7.1701","article-title":"Diabetes and gastric cancer: The potential links","volume":"20","author":"Tseng","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_50","unstructured":"(2023, July 07). International Agency for Research on Cancer. IARC. Available online: https:\/\/gco.iarc.fr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJM199312303292701","article-title":"Prevention of colorectal cancer by colonoscopic polypectomy: The National Polyp Study Workgroup","volume":"329","author":"Winawer","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"g2467","DOI":"10.1136\/bmj.g2467","article-title":"Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: Systematic review and meta-analysis of randomized controlled trials and observational studies","volume":"348","author":"Brenner","year":"2014","journal-title":"BMJ"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1007\/s10620-012-2055-1","article-title":"Diabetes mellitus and the incidence of colorectal cancer: An updated systematic review and meta-analysis","volume":"57","author":"Deng","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3346\/jkms.2011.26.9.1196","article-title":"Korean type 2 diabetes patients have multiple adenomatous polyps compared to non-diabetic controls","volume":"26","author":"Suh","year":"2011","journal-title":"J. Korean Med. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/dia.2012.0263","article-title":"Diabetes mellitus and the occurrence of colorectal cancer: An updated meta-analysis of cohort studies","volume":"15","author":"Wu","year":"2013","journal-title":"Diabetes Technol. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/ajg.2011.301","article-title":"Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?","volume":"106","author":"Yuhara","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1055\/a-0959-0505","article-title":"Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline\u2014Update 2019","volume":"51","author":"Hassan","year":"2019","journal-title":"Endoscopy"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00125-003-1109-5","article-title":"Hyperinsulinaemia and hyperglycaemia: Possible risk factors of colorectal cancer among diabetic patients","volume":"46","author":"Chang","year":"2003","journal-title":"Diabetologia"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/1878-0261.12531","article-title":"Diabetes-mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction","volume":"13","author":"Gonzalez","year":"2019","journal-title":"Mol. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"li Khan, U., Fallah, M., Sundquist, K., Hemminki, K., and Sundquist, J. (2020). Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study. PLoS Med., 17.","DOI":"10.1371\/journal.pmed.1003431"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2021). Standards of medical care in diabetes\u20142022. Diabetes Care, 45, S1\u2013S2.","DOI":"10.2337\/dc22-Sint"},{"key":"ref_62","first-page":"102369","article-title":"Synergistic interaction of diabetes and hepatitis B on liver cancer risk: Meta-analysis","volume":"86","author":"Zhou","year":"2023","journal-title":"Cancer Epidemiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_64","first-page":"2080","article-title":"The diagnosis and management of MASLD: Practice guidance from the AASLD","volume":"74","author":"Chalasani","year":"2021","journal-title":"Hepatology"},{"key":"ref_65","first-page":"20","article-title":"MASLD-related HCC: Non-cirrhotic pathways and predictive markers","volume":"80","author":"Petroni","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_66","first-page":"1489","article-title":"MASLD progression to HCC: A global perspective","volume":"161","author":"Loomba","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_67","first-page":"135","article-title":"Type 2 diabetes and hepatocellular carcinoma risk among hepatitis B patients: A population-based cohort study","volume":"42","author":"Chen","year":"2022","journal-title":"Liver Int."},{"key":"ref_68","first-page":"961","article-title":"Diabetes and the risk of hepatocellular carcinoma in chronic liver diseases","volume":"71","author":"Wong","year":"2020","journal-title":"Hepatology"},{"key":"ref_69","first-page":"99","article-title":"Gallbladder cancer: Epidemiology and outcome","volume":"6","author":"Hundal","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/dmrr.2671","article-title":"Type 2 diabetes mellitus and risk of gallbladder cancer: A systematic review and meta-analysis of observational studies","volume":"32","author":"Gu","year":"2016","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma","volume":"54","author":"Tyson","year":"2011","journal-title":"Hepatology"},{"key":"ref_72","first-page":"1545","article-title":"New and emerging treatment options for biliary tract cancer","volume":"6","author":"Noel","year":"2013","journal-title":"OncoTargets Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nm1785","article-title":"Hepatic insulin resistance directly promotes the formation of cholesterol gallstones","volume":"14","author":"Biddinger","year":"2008","journal-title":"Nat. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.22606","article-title":"Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans","volume":"49","author":"Engels","year":"2009","journal-title":"Hepatology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1007\/s00432-023-04759-2","article-title":"Anxiety in patients with gastrointestinal cancer undergoing primary surgery","volume":"149","author":"Harms","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4093\/dmj.2019.0177","article-title":"Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment","volume":"43","author":"Suh","year":"2019","journal-title":"Diabetes Metab. J."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/18\/2989\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:44:46Z","timestamp":1760035486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/18\/2989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":76,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cancers17182989"],"URL":"https:\/\/doi.org\/10.3390\/cancers17182989","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]}}}